Applied Molecular Transport (AMT) is a privately held, clinical-stage biopharmaceutical company that is applying its proprietary bioengineering technology platform to create transformative oral biological therapies for patients with severe autoimmune, metabolic and inflammatory diseases. The company is headquartered in South San Francisco, California.
In the News
Applied Molecular Transport Appoints Industry Veteran Shawn Cross as Chief Financial Officer and Promotes Bittoo Kanwar, M.D. to Chief Medical Officer
Applied Molecular Transport’s Proprietary Approach to Designing Oral Biologic Therapeutics Published in Tissue Barriers Journal
Applied Molecular Transport Presents Preclinical Data on AMT-101, an Oral GI-selective rhIL-10 at European Crohn’s and Colitis Organisation (ECCO)
No events scheduled at this time.